S-1 · primary offering
Issued 2023
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: OTC
DilutionScan read 46 of VACCINEX, INC.'s SEC filings and found 13 warrant series, 2 convertibles, 1 ATM program, 14 shelf registrations, 2 S-1 registrations and 5 completed offerings on file for VCNX. The latest dilution event on file is ATM sales on Dec 31, 2024. Analysis updated Nov 4, 2026.
Raise routes on file: no active ATM, effective shelf, S-1 or equity line in the filings read · latest dilution event 673 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Dec 31, 2024 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2023
Proposed maximum
Shares registered
Issued 2023
Proposed maximum
Shares registered
Issued 2024
Shares Underlying
Exercise Price
Issued 2024
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Issued 2024
Shares Underlying
Exercise Price
Principal
Conversion Price
Principal
Conversion Price
Issued 2020
Total capacity
Sold to date
Issued 2019
Total capacity
Remaining
Issued 2020
Total capacity
Remaining
Issued 2020
Total capacity
Remaining
Issued 2020
Total capacity
Remaining
Issued 2020
Total capacity
Remaining
Issued 2022
Total capacity
Remaining
Issued 2024
Gross proceeds
Price per share
Issued 2024
Gross proceeds
Price per share
Issued 2024
Gross proceeds
Price per share
Issued 2024
Gross proceeds
Price per share
Issued 2024
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z